Publication Author: Sullivan_Sean

• The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.

  Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention worksho

  rakerr2

  February 17, 2015

• Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response.

  Lee CI, Gold LS, Nelson HD, Chou R, Ramsey SD, Sullivan SD. Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. Breast. 2015 Feb;24(1):3-11. doi: 10.1016/j.breast.2014.11.009. Epub 2014 Dec 3. Review.

  rakerr2

  February 1, 2015

• Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.

  Seal B, Sullivan SD, Ramsey S, Asche CV, Shermock KM, Sarma S, Zagadailov E, Farrelly E, Eaddy M. Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting. Future Oncol. 201

  rakerr2

  February 1, 2015

• Implementing Lung Cancer Screening Using Low-Dose Computed Tomography: Recommendations From an Expert Panel.

  Ramsey SD, Malin JL, Goulart B, Ambrose LF, Kanne JP, McKee AB, Reed SD, Schwartz JS, Sullivan SD. Implementing Lung Cancer Screening Using Low-Dose Computed Tomography: Recommendations From an Expert Panel. J Oncol Pract. 2015 Jan;11(1):e44-9. doi: 10.12

  rakerr2

  January 1, 2015

• Cost-effectiveness: the authors reply.

  Pauly MV, Sloan FA, Sullivan SD. Cost-effectiveness: the authors reply. Health Aff (Millwood). 2015 Jan 1;34(1):188. doi: 10.1377/hlthaff.2014.1374.

  rakerr2

  January 1, 2015

• Health care costs among renal cancer patients using pazopanib and sunitinib.

  Hansen RN, Hackshaw MD, Nagar SP, Arondekar B, Deen KC, Sullivan SD, Ramsey SD. Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm. 2015 Jan;21(1):37-44.

  rakerr2

  January 1, 2015

• Asthma Control and Cost in Latin America.

  Gold LS, Montealegre F, Allen-Ramey FC, Jardim J, Sansores R, Sullivan SD. Asthma Control and Cost in Latin America. Value Health Reg Issues. 2014 Dec;5:25-28. doi: 10.1016/j.vhri.2014.06.007. Epub 2014 Jul 18.

  rakerr2

  December 1, 2014

• An economic framework for preventive care advice.

  Pauly MV, Sloan FA, Sullivan SD. An economic framework for preventive care advice. Health Aff (Millwood). 2014 Nov;33(11):2034-40. doi: 10.1377/hlthaff.2013.0873.

  rakerr2

  November 1, 2014

• Real-world evaluation of the effects of counseling and education in diabetes management.

  Dalal MR, Robinson SB, Sullivan SD. Real-world evaluation of the effects of counseling and education in diabetes management. Diabetes Spectr. 2014 Nov;27(4):235-43. doi: 10.2337/diaspect.27.4.235.

  rakerr2

  November 1, 2014

• Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios.

  Hoogendoorn M, Feenstra T, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs A, Lloyd A, Sullivan SD, Rutten-van Mölken MP. Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothet

  rakerr2

  November 1, 2014